1)Centers for Disease Control and Prevention : CDC WONDER(Wide-ranging ONline Data for Epidemiologic Research) https://wonder.cdc.gov/ (URLは2018年12月25日閲覧)
2)American Academy of Pain Medicine, the American Pain Society and the American Society of Addition Medicine ; Definitions related to the use of opioids for the treatment of pain. WMJ 100(5) : 28-29, 2001. PMID 11579797
3)McNicol E : Opioid side effects and their treatment in patients with chronic cancer and noncancer pain. J Pain Palliat Care Pharmacother 22(4) : 270-281, 2008. PMID 21923311
4)Morley JE : The endocrinology of the opiates and opioid peptides. Metabolism 30(2) : 195-209, 1981. PMID 6258010
5)Hardy J, et al : A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer 10(3) : 231-236, 2002. PMID 11904788
6)Merza Z : Chronic use of opioids and the endocrine system. Horm Metab Res 42(9) : 621-626, 2010. PMID 20486065
7)日本緩和医療学会 緩和医療ガイドライン委員会(編):がん疼痛の薬物療法に関するガイドライン.第2版,金原出版,2014.